With a market cap of $394.2 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company ...

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

As researchers and governments consider the therapeutic uses of psychedelics, Scott Marshall stands ready to supply them.

Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more concerned about young Americans ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

Many Indians laid low by disease have turned to biohacking. Others are healthy but want to live longer. Aiding them in their ...

The ARTfactory’s Actors Theatre will bring Every Brilliant Thing to the stage in an intimate, thought-provoking performance ...